Transplantation of adipose tissue lacking PAI-1 improves glucose tolerance and attenuates cardiac metabolic abnormalities in high-fat diet-induced obesity

References

• Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell. 2014;156:20–44.
   PubMed Web of Science ®Google Scholar
• Wang L, Chen L, Liu Z, et al. PAI-1 exacerbates white adipose tissue dysfunction and metabolic dysregulation in high fat diet-induced obesity. Front Pharmacol. 2018;9:1087.
   PubMed Web of Science ®Google Scholar
• Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548–2556.
   PubMed Web of Science ®Google Scholar
• Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444:847–853.
   PubMed Web of Science ®Google Scholar
• Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab. 2004;30:13–19.
   PubMed Web of Science ®Google Scholar
• Villena JA, Choi CS, Wang Y, et al. Resistance to high-fat diet–induced obesity but exacerbated insulin resistance in mice overexpressing preadipocyte factor-1 (Pref-1): a new model of partial lipodystrophy. Diabetes. 2008;57(12):3258–3266.
   PubMed Web of Science ®Google Scholar
• Ma LJ, Mao SL, Taylor KL, et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes. 2004;53:336–346.
   PubMed Web of Science ®Google Scholar
• Tran TT, Yamamoto Y, Gesta S, et al. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 2008;7:410–420.
   PubMed Web of Science ®Google Scholar
• Hocking SL1, Stewart RL, Brandon AE, et al. Subcutaneous fat transplantation alleviates diet-induced glucose intolerance and inflammation in mice. Diabetologia. 2015;58:1587–1600.
   PubMed Web of Science ®Google Scholar
• Stanford KI, Middelbeek RJ, Townsend KL, et al. A Novel role for subcutaneous adipose tissue in exercise-induced improvements in glucose homeostasis. Diabetes. 2015;64(6):2002–2014.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang L, Li Y, et al. Transplantation of normal adipose tissue improves blood flow and reduces inflammation in high fat fed mice with hindlimb ischemia. Front Physiol. 2018;9:197.
   PubMed Web of Science ®Google Scholar
• Carmeliet P1, Kieckens L, Schoonjans L, et al. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest. 1993;92:2746–2755.
   PubMed Web of Science ®Google Scholar
• Hazarika S, Dokun AO, Li Y, et al. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1. Circ Res. 2007;101:948–956.
   PubMed Web of Science ®Google Scholar
• Li R, Li K, Zhang L, et al. Autologous transplantation of photoactivated subcutaneous adipose tissue improves glucose homeostasis in high‐fat diet‐induced obese mice. J Tissue Eng Regen Med. 2019;13(9):1609–1617.
   PubMed Web of Science ®Google Scholar
• Xu Z, Castellino FJ, Ploplis VA. Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture. Blood. 2010;115:2038–2047.
   PubMed Web of Science ®Google Scholar
• Furumoto T, Fujii S, Onozuka H, et al. Loss of insulin receptor substrate-1 signaling induces the cardiovascular and proteo(fibrino)lytic system derangements typical of insulin resistance. Coron Artery Dis. 2005;16(2):117–123.
   PubMed Web of Science ®Google Scholar
• Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85–97.
   PubMed Web of Science ®Google Scholar
• Buchanan J1, Mazumder PK, Hu P, et al. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology. 2005;146:5341–5349.
   PubMed Web of Science ®Google Scholar
• Peterson LR1, Herrero P, KB S, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004;109:2191–2196.
   PubMed Web of Science ®Google Scholar
• Rijzewijk LJ, van der Meer RW, Lamb HJ, et al. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol. 2009;54:1524–1532.
   PubMed Web of Science ®Google Scholar
• Renguet E, Ginion A, Gélinas R, et al. Metabolism and acetylation contribute to leucine-mediated inhibition of cardiac glucose uptake. Am J Physiol Heart Circ Physiol. 2017;313(2):H432–H445.
   PubMed Web of Science ®Google Scholar
• Di Lisa F, Ziegler M. Pathophysiological relevance of mitochondria in NAD(+) metabolism. FEBS Lett. 2001;492:4–8.
   PubMed Web of Science ®Google Scholar
• Berthiaume JM, Kurdys JG, Muntean DM, et al. Mitochondrial NAD+/NADH redox state and diabetic cardiomyopathy. Antioxid Redox Signal. 2019;30(3):375–398.
   PubMed Web of Science ®Google Scholar
• Williams LJ, Nye BG, Wende AR. Diabetes-related cardiac dysfunction. Endocrinol Metab (Seoul). 2017;32(2):171–179.
   PubMedGoogle Scholar
• Kolwicz SC Jr, Tian R. Glucose metabolism and cardiac hypertrophy. Cardiovasc Res. 2011;90:194–201.
   PubMed Web of Science ®Google Scholar
• Cannon MV, Silljé HH, Sijbesma JW, et al. Cardiac LXRa protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization. EMBO Mol Med. 2015;7(9):1229–1243.
   PubMed Web of Science ®Google Scholar